Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,711 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 381
Ph III recruiting: 44
Growth YoY: +8.6%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (277)

clinicaltrialsPublishedShowing 51–100 of 114 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07478705	Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging(EINSTEIN-TNBC)	not yet recruiting	N/A	30	Sunnybrook Health Sciences CentreOTHER	0	Mar 17, 2026	clinicaltrials
NCT07470203	Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer	not yet recruiting	—	42	Peking University Cancer Hospital & InstituteOTHER